Our institutional experience with pediatric spinal cord tumors includes 25 patients with the diagnosis of ependymoma (EP; n = 4), myxopapillary ependymoma (MPEP; n = 4), juvenile pilocytic astrocytoma (JPA; n = 5), nonpilocytic astrocytoma (WHO grade I or II, n = 6), and other nonastrocytic spinal cord tumors (n = 6) treated during the period 1974–1999. Nineteen patients required radiation therapy (RT). The median progression-free survival following RT was 65 months (range 1–206 months). Seven patients recurred at an average of 22 months. The EP patients recurred at an average of 8.5 months, while the patients with low-grade astrocytoma recurred at an average of 42 months. Including the 6 nonsurviving patients, the median overall survival was 96 months. Two EP patients died with a progression-free survival of 9 months. One patient with MPEP died of other causes at 7 months. The treatment of pediatric spinal cord tumors should be individualized based on the histologic type. Radical surgery is indicated for nonmyxopapillary EP and low-grade astrocytic tumors. The need for adjuvant therapy most often depends on the extent of resection as well as the tumor type. Patients with disseminated EP, MPEP, JPA and nonpilocytic astrocytoma may achieve long-term progression-free survival with craniospinal irradiation.

Keywords:
Radiotherapy, Central nervous system neoplasms, Spinal cord tumors, Ependymoma, Astrocytoma, Craniospinal irradiation
1.
Merchant TE, Nguyen D, Thompson SJ, Reardon DA, Kun LE, Sanford RA: High-grade pediatric spinal cord tumors. Pediatr Neurosurg 1999;30:1–5.
2.
McCormick PC, Torres R, Post KD: Intramedullary ependymoma of the spinal cord. J Neurosurg 1990;72:523–532.
3.
Melman CT, Crawford AH, McMath JA: Pediatric vertebral and spinal cord tumors: A retrospective study of musculoskeletal aspects of presentation, treatment, and complications. Orthopedics 1999;22:49–56.
4.
Lonjon M, Goh KYC, Epstein FJ: Intramedullary spinal cord ependymomas in children: Treatment, results and follow-up. Pediatr Neurosurg 1998;29:178–183.
5.
Goh KYC, Velasquez L, Epstein FJ: Pediatric intramedullary spinal cord tumors: Is surgery alone enough? Pediatr Neurosurg 1997;27:34–39.
6.
Lowis SP, Pizer BL, Coakham H, Nelson RJ, Bouffet E: Chemotherapy for spinal cord astrocytoma: Can natural history be modified? Childs Nerv Syst 1998;14:317–321.
7.
Schild SE, Nisi K, Scheithauer BW, Wong WW, Lyons MK, Schomberg PJ, Shaw EG: The results of radiotherapy for ependymomas: The Mayo Clinic experience. Int J Radiat Oncol Biol Phys 1998;42:953–958.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.